Nitazoxanide: Difference between revisions
ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: Antiparasitic, active against giardia and cryptosporidium *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: ==Adult D...") |
ClaireLewis (talk | contribs) |
||
Line 47: | Line 47: | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:ID]] |
Latest revision as of 23:55, 22 September 2019
Administration
- Type: Antiparasitic, active against giardia and cryptosporidium
- Dosage Forms:
- Routes of Administration: Oral
- Common Trade Names:
Adult Dosing
- 500mg PO BID x 3 days
Pediatric Dosing
- 1-3yo: 100mg BID x 3 days
- 4-11yo: 200mg BID x 3 days
- >11yo: 500mg BID x 3 days
Special Populations
- Pregnancy Rating: B
- Lactation risk: infant risk cannot be ruled out
- Renal dosing:
- Hepatic dosing:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
- Abdominal pain, nausea
- Headache
- Abnormal color of urine
Pharmacology
- Half-life: 1-1.6h
- Metabolism:
- Excretion: Mostly fecal
Mechanism of Action
- inhibits pyruvate ferredoxin oxidoreductase, which is essential to anaerobic energy metabolism